Book a Demo
Platform Overview
Features
Cardiac Amyloidosis Heart Failure Aortic Stenosis Pulmonary Hypertension Strain Stress Echocardiography
Operations
Operational Impact Deployment & Security Integrations Core Lab Solutions EHR Mining Partnerships
Tools
ROI Calculator Reimbursements Peer Comparison Regulatory Status
Library & news
Clinical Evidence Case Studies News
Our Story Careers Media Kit

Reimbursement for AI Echocardiography Worldwide

Country-specific coding, payment methodology, and coverage detail across 13 markets where Us2.ai is cleared or registered, plus a 9-market bundle. Pick your market below.

How Payment Models Vary

Echocardiography sits within five broad reimbursement archetypes worldwide. Understanding which archetype applies in your market shapes the value case for AI-assisted reporting.

Fee-for-Service

US Medicare (CPT 93306, 0932T HFpEF), Australia (MBS 55126 family), Canada (provincial G-codes), Germany GOÄ (private). Per-study revenue scales directly with volume.

Point-Based

Germany EBM, Japan NHI (1 pt = ¥10), Taiwan NHI / NHIA. A procedure earns points converted to local currency via a periodically adjusted point-value, sometimes constrained by an annual global budget envelope.

HRG / Case-Mix Bundled

UK NHS HRG (RD50Z / RD51A), France T2A / GHS inpatient, Germany G-DRG inpatient, Indonesia BPJS INA-CBG, Thailand UCS DRG. Echo is bundled within the case payment for the admission or episode.

Health Benefit Packages

India PM-JAY (Ayushman Bharat) HBPs, Philippines PhilHealth Z-benefit cardiac packages. Multi-component cardiac pathways bundled into a single high-value case rate.

Budget-Funded

New Zealand Te Whatu Ora, public hospital systems globally, Hong Kong Hospital Authority. No per-study tariff; AI value case is throughput and length-of-stay within the budget envelope.

Mixed Private / Self-Pay

UK CCSD (BUPA, AXA Health, Vitality, WPA), Brazil ANS / TUSS, Singapore MediShield Life, UAE DHA / DoH, India commercial insurance. Negotiated tariffs typically pay multiples of the public-pillar rate.

Frequently Asked Questions

Common questions about echocardiography reimbursement worldwide. For country-specific detail, see the relevant market page above.

Why are there separate pages per country?
Echocardiography coding, payment methodology, indicative tariffs, and AI-specific considerations differ materially between countries. The US uses CPT codes and a dedicated AI HFpEF Category III code; the UK bundles into NHS HRGs; Germany separates statutory GKV (EBM points), inpatient G-DRG, and private GOÄ; Australia uses MBS fee-for-service; Japan and Taiwan use point-based national insurance. A single page can't carry that detail accurately, so each market is documented on its own page.
How do US, UK, EU, and APAC payment models compare?
The US Medicare model is fee-for-service with CPT codes plus a Category III code (0932T) specifically recognising AI-derived HFpEF detection. NHS England uses HRG-based bundled payment (no AI-specific code yet); Germany separates statutory GKV outpatient (EBM points), inpatient (OPS / G-DRG bundled), and private (GOÄ multiplier). Australia uses fee-for-service under MBS, Japan uses point-based NHI (1 pt = ¥10), and APAC markets like Indonesia / Thailand rely heavily on case-mix bundled (INA-CBG, DRG) payment.
Is there an AI-specific reimbursement code outside the US?
As of the current published schedules, the United States is the only market with a procedure-level code dedicated to AI-derived heart-failure detection (CPT Category III 0932T, effective 1 January 2025). Outside the US, AI-assisted reporting today sits within the existing echo codes; the value case is built around throughput, report turnaround, and report quality. Several markets including the UK, Germany, Japan, and France are reviewing AI-specific reimbursement pathways.
Where can I find coding for a market not listed?
Us2.ai holds regulatory clearance or registration in 28+ markets. The 13 country pages and the 9-market bundle cover all markets where we currently document reimbursement detail. For any market not listed (e.g. Saudi Arabia, Egypt, South Korea, Italy, Spain), please contact us with your country and intended clinical use and we will provide guidance against the live local schedule.
How current is the data on each country page?
Each page documents the schedule, codes, and indicative fees in effect at the time of writing. Sources are cited in the file header (e.g. KBV for Germany EBM, MBS Online for Australia, MHLW for Japan, NHS England for UK HRGs). Tariffs, point values, and case-mix weights change periodically; verify against the live local schedule before relying on figures for financial planning.
Where does regulatory status sit?
See Regulatory Status for the full clearance and registration list across 28+ markets, with certificate numbers where available. Each row links back to the matching reimbursement deep dive or bundle.

Important Information

Information across the country pages is provided for general informational purposes only and is not a guarantee of coverage or reimbursement. Local schedules, hospital tier classifications, case-mix group rates, insurer contracts, and AI-specific reimbursement pathways are subject to change. Providers should verify against the relevant local authority before relying on figures for financial planning. CPT is a registered trademark of the American Medical Association.

Need detail on a specific market?

Our team can support business cases with current local context, regulatory documentation, and clinical evidence tailored to your country, buying centre, and intended clinical use.

Contact Us